We are live on
!
Find out more
NIM
Northeast Investment Management Portfolio holdings
AUM
$2.71B
1-Year Est. Return
25.45%
This Fund
S&P 500
This Quarter
Est. Return
+2.33%
1 Year Est. Return
+25.45%
3 Year Est. Return
+93.39%
5 Year Est. Return
+114.23%
10 Year Est. Return
+466.58%
AUM
$994M
AUM Growth
+$21.1M
(+2.2%)
Cap. Flow
+$3.98M
Cap. Flow
% of AUM
0.4%
Top 10 Holdings %
Top 10 Hldgs %
27.23%
Holding
159
New
6
Increased
56
Reduced
71
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$4.26M |
| 2 |
Church & Dwight Co
CHD
|
+$2.04M |
| 3 |
Meta Platforms (Facebook)
META
|
+$2.03M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$2.01M |
| 5 |
Starbucks
SBUX
|
+$1.94M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$4.38M |
| 2 |
SF
Stifel
SF
|
+$2.76M |
| 3 |
Abbott
ABT
|
+$2M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$1.91M |
| 5 |
Walt Disney
DIS
|
+$1.38M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.49% |
| 2 | Financials | 12.74% |
| 3 | Industrials | 12.38% |
| 4 | Consumer Discretionary | 10.08% |
| 5 | Technology | 9.58% |
Similar funds
FNF
NB
NCM
TAM
CA
BCM
SCM
XL
Northeast Investment Management's Q2 2016 Portfolio in Review
As of Q2 2016, Northeast Investment Management held 159 positions worth $994M, up 2.2% from $973M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Northeast Investment Management's Q2 2016 filing shows 6 new, 56 increased, 71 reduced and 4 closed positions. Its largest new stake was Becton Dickinson: 7,355 shares worth $1.22M. The largest sale was Novartis, an estimated $4.38M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Financials and Industrials.
- Northeast Investment Management's largest Q2 2016 buy was Becton Dickinson: 7,355 shares worth $1.22M.
- Northeast Investment Management added most to Thermo Fisher Scientific in Q2 2016, an estimated $4.26M increase.
- Northeast Investment Management's biggest Q2 2016 reduction was Novartis, cutting an estimated $4.38M.
- Northeast Investment Management fully exited Biogen in Q2 2016, selling an estimated $431K.
- Northeast Investment Management's ten largest holdings make up 27% of its $994M portfolio in Q2 2016.
- Northeast Investment Management opened 6 new positions and closed 4 in Q2 2016.
- Northeast Investment Management's portfolio value rose 2.2% quarter-over-quarter to $994M.
Based on Northeast Investment Management's 13F filing for Q2 2016, filed 2 Aug 2016.